PTEN and cancer: Regarding the anticancer properties of IFN-γ [7, 50, 51], the implication of PI3K/PTEN/galectin-3/AKT/GSK-3β/SHP2 signaling might reflect a strategy hijacked by cancer cells to cause cellular unresponsiveness to IFN-γ.